Journal Report

Journal of Clinical Oncology

Download PDF
Journal Information
Journal Title
Journal of Clinical Oncology
Publisher
Lippincott Williams and Wilkins
ISSN
0732-183X
E-ISSN
1527-7755
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Association Between Patient-Reported Outcomes and Health Care Resource Utilization: Toward Developing Patient-Centered Value Measures in Cancer Care
Dhruvin H. Hirpara, Andreea C. Matei, Rinku Sutradhar et al.
2026-11-1 Vol. 44 Issue 31 Pages 3026-3035
Corticosteroids in Glioblastoma Management: A Reconsideration of a 65-Year Practice
Bertrand Liang, Michael Weil
2026-11-1 Vol. 44 Issue 31 Pages 2990-2993
Avatrombopag Versus Placebo for Persistent Chemotherapy-Induced Thrombocytopenia in GI Cancers: The Phase II ACT-GI Trial
Hanny Al-Samkari, Joseph J. Shatzel, Sandhya R. Panch et al.
2026-11-1 Vol. 44 Issue 31 Pages 3006-3014
Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1.4
Mary-Ellen Taplin, Rahul A. Parikh, R. Bryan Rumble et al.
2026-11-1 Vol. 44 Issue 31
Bridging the Gap: Clinical Integration of Thrombopoietin Receptor Agonists in GI Cancer–Associated Chemotherapy-Induced Thrombocytopenia
Raafat S. Alameddine, Timothy J. Brown, Nicholas J. Hornstein et al.
2026-11-1 Vol. 44 Issue 31 Pages 2985-2989
Reply to: Time-Varying Effects of Copy Number Alteration Clustering: Methodologic Concerns in Survival Analysis of Relapsed/Refractory Germ Cell Tumors
Milena Urbini, Thomas F. Eleveld, Maurizio Polano et al.
2026-11-1 Vol. 44 Issue 31 Pages 3075-3077
Risk-Adapted Optimization of Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2–Positive Early-Stage Breast Cancer
Sam O. Kleeman, Vered Stearns
2026-11-1 Vol. 44 Issue 31 Pages 3048-3060
Trastuzumab Botidotin Versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A Phase III, Open-Label, Randomized Controlled Trial
Jian Zhang, Quchang Ouyang, Qingyuan Zhang et al.
2026-11-1 Vol. 44 Issue 31 Pages 3036-3047
Thrombopoietin Receptor Agonists for Chemotherapy-Induced Thrombocytopenia in GI Cancers: A Big Solution for a Small Problem or a Solution at All?
E. Gabriela Chiorean, Ardaman Shergill
2026-11-1 Vol. 44 Issue 31 Pages 2981-2984
Erratum: Five-Year Outcomes of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy for Locally Advanced Rectal Cancer: Updated Results of the STELLAR Trial
Yuan Tang, Hai-Tao Zhou, Tong-Zhen Xu et al.
2026-11-1 Vol. 44 Issue 31 Pages 3078-3078
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 1, 2026 09:38